Catechins as Tools to Understand the Molecular Basis of Neurodegeneration

被引:34
|
作者
Pomier, Karla Martinez [1 ]
Ahmed, Rashik [2 ]
Melacini, Giuseppe [1 ,2 ]
机构
[1] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada
[2] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada
来源
MOLECULES | 2020年 / 25卷 / 16期
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
Alzheimer's Disease; amyloid beta; catechin; EGCG; NMR; alpha-synuclein; GREEN TEA CATECHINS; HUMAN SERUM-ALBUMIN; A-BETA-PEPTIDE; ATOMIC-RESOLUTION MAP; FORMATION IN-VITRO; ALPHA-SYNUCLEIN; AMYLOID-BETA; EPIGALLOCATECHIN GALLATE; POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; ALZHEIMERS-DISEASE;
D O I
10.3390/molecules25163571
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein misfolding as well as the subsequent self-association and deposition of amyloid aggregates is implicated in the progression of several neurodegenerative disorders including Alzheimer's and Parkinson's diseases. Modulators of amyloidogenic aggregation serve as essential tools to dissect the underlying molecular mechanisms and may offer insight on potential therapeutic solutions. These modulators include green tea catechins, which are potent inhibitors of amyloid aggregation. Although catechins often exhibit poor pharmacokinetic properties and bioavailability, they are still essential tools for identifying the drivers of amyloid aggregation and for developing other aggregation modulators through structural mimicry. As an illustration of such strategies, here we review how catechins have been used to map the toxic surfaces of oligomeric amyloid-like species and develop catechin-based phenolic compounds with enhanced anti-amyloid activity.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration
    Azam, Shofiul
    Haque, Md Ezazul
    Balakrishnan, Rengasamy
    Kim, In-Su
    Choi, Dong-Kug
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 09
  • [2] α-Synuclein and Polyunsaturated Fatty Acids: Molecular Basis of the Interaction and Implication in Neurodegeneration
    Fecchio, Chiara
    Palazzi, Luana
    de Laureto, Patrizia Polverino
    MOLECULES, 2018, 23 (07):
  • [3] Molecular basis of vitamin D action in neurodegeneration: the story of a team perspective
    Duygu Gezen-Ak
    Erdinç Dursun
    Hormones, 2019, 18 : 17 - 21
  • [4] Molecular basis of vitamin D action in neurodegeneration: the story of a team perspective
    Gezen-Ak, Duygu
    Dursun, Erdinc
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2019, 18 (01): : 17 - 21
  • [5] Molecular mechanisms of α-synuclein neurodegeneration
    Waxman, Elisa A.
    Giasson, Benoit I.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (07): : 616 - 624
  • [6] Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease
    Jeong, Sangyun
    MOLECULES AND CELLS, 2017, 40 (09) : 613 - 620
  • [7] From Menopause to Neurodegeneration-Molecular Basis and Potential Therapy
    Cheng, Yu-Jung
    Lin, Chieh-Hsin
    Lane, Hsien-Yuan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [8] Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration
    Friedland, Robert P.
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 45 (02) : 349 - 362
  • [9] DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications
    Abbassi, Ramzi
    Johns, Terrance G.
    Kassiou, Michael
    Munoz, Lenka
    PHARMACOLOGY & THERAPEUTICS, 2015, 151 : 87 - 98
  • [10] Molecular Binding of Catechins to Biomembranes: Relationship to Biological Activity
    Sirk, Timothy W.
    Brown, Eugene F.
    Friedman, Mendel
    Sum, Amadeu K.
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2009, 57 (15) : 6720 - 6728